Pharmaceuticals - Solna, Stockholm County, Sweden
Genagon Therapeutics drug development is based on ground-breaking discoveries of unstudied proteins and their life cycles in innate immune cells. Genagon was founded in 2015 and is growing a strong and broad patent portfolio with opportunities for internal development and future partnerships. The company is supported financially by among others, Beijer Ventures and Almi Invest.
Outlook
Binero
WordPress.org
Google Font API
Google Maps (Non Paid Users)